Healthcare provider profile · identity verified

Sumit Som, M.D.

Preventive Medicine · CLARKSVILLE, IN · NPI 1235559451

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	377	118
Amlodipine Besylate	Amlodipine Besylate	233	66
Levothyroxine Sodium	Levothyroxine Sodium	216	58
Lisinopril	Lisinopril	189	51
Losartan Potassium	Losartan Potassium	186	55
Omeprazole	Omeprazole	170	54
Metoprolol Succinate	Metoprolol Succinate	127	39
Metformin Hcl Er	Metformin Hcl	122	35
Furosemide	Furosemide	117	43
Pravastatin Sodium	Pravastatin Sodium	114	32
Rosuvastatin Calcium	Rosuvastatin Calcium	108	39
Tamsulosin Hcl	Tamsulosin Hcl	108	34
Pantoprazole Sodium	Pantoprazole Sodium	93	34
Albuterol Sulfate Hfa	Albuterol Sulfate	85	26
Duloxetine Hcl	Duloxetine Hcl	80	17
Eliquis	Apixaban	78	17
Meloxicam	Meloxicam	75	24
Hydrochlorothiazide	Hydrochlorothiazide	74	21
Simvastatin	Simvastatin	72	23
Allopurinol	Allopurinol	70	19
Gabapentin	Gabapentin	68	20
Metformin Hcl	Metformin Hcl	64	20
Trazodone Hcl	Trazodone Hcl	61	18
Glimepiride	Glimepiride	60	21
Montelukast Sodium	Montelukast Sodium	60	20
Potassium Chloride	Potassium Chloride	60	17
Sertraline Hcl	Sertraline Hcl	59	18
Carvedilol	Carvedilol	54	15
Metoprolol Tartrate	Metoprolol Tartrate	51	20
Citalopram Hbr	Citalopram Hydrobromide	50	17
Clopidogrel	Clopidogrel Bisulfate	49	15
Lorazepam	Lorazepam	44	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	42	14
Mounjaro	Tirzepatide	42	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	14
Famotidine	Famotidine	40	15
Alprazolam	Alprazolam	38	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	38	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	suppressed
Alendronate Sodium	Alendronate Sodium	34	suppressed
Topiramate	Topiramate	33	suppressed
Bumetanide	Bumetanide	32	suppressed
Bupropion Xl	Bupropion Hcl	31	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Diclofenac Sodium	Diclofenac Sodium	30	11
Fluticasone Propionate	Fluticasone Propionate	29	13
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Farxiga	Dapagliflozin Propanediol	28	suppressed
Linzess	Linaclotide	28	suppressed
Ozempic	Semaglutide	28	suppressed
Azithromycin	Azithromycin	26	23
Pioglitazone Hcl	Pioglitazone Hcl	26	12
Warfarin Sodium	Warfarin Sodium	25	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Methocarbamol	Methocarbamol	23	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Atenolol	Atenolol	22	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Celecoxib	Celecoxib	22	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Jardiance	Empagliflozin	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Torsemide	Torsemide	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Amoxicillin	Amoxicillin	17	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Scopolamine	Scopolamine	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Baclofen	Baclofen	14	suppressed
Clonazepam	Clonazepam	14	suppressed
Finasteride	Finasteride	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	11
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Tramadol Hcl	Tramadol Hcl	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Nystatin	Nystatin	12	suppressed
Prednisone	Prednisone	12	12
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Alogliptin	Alogliptin Benzoate	11	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Estradiol	Estradiol	11	suppressed
Klor-Con M10	Potassium Chloride	11	suppressed
Nexium	Esomeprazole Magnesium	11	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error